Bayer: Betting Big on Cell & Gene Therapy
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell and gene therapies to…
Address: Heimeranstrasse 35, Munich,Germany
Tel: +49 89 893119-0
FGK clinical research is a full service contract research organisation offering a complete range of clinical development and consulting services to pharmaceutical, biotechnology and medical device companies.With more than 50 highly skilled and experienced people, FGK operates out of Munich on local and global projects, covering clinical studies from phases I to IV. FGK has extensive experience in all major therapeutic areas and clinical research fields, which allows it to effectively design, manage and analyze its clients’ development programs and clinical trials.FGK works with a network of carefully selected partner companies to provide a range of services to complement its own. The company therefore offers monitoring services all over Europe and the US. It is also able to provide you access to and expertise in leading EDC technologies, which helps provide high-quality clinical trial data in the shortest possible time.FGK also provides expertise in global product development and statistical and regulatory compliance in order to assist biotech and medical device companies in the design and execution of adequate clinical studies and global development strategies.
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell and gene therapies to…
German giant Merck KGaA has announced a EUR one billion investment into its headquarters in Darmstadt, Germany up until 2025. The aim of Merck’s proposed investment is to secure…
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth through acquisition in this extremely competitive and challenging global…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with Germany at the center of this process on the European continent. An example…
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout the market for its long-term vision. How would you compare this…
Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in emerging markets, due to the increased prevalence of the disease in countries…
You joined Cegedim in summer 2006 eleven months before its merger with Dendrite in 2007 that created the world leader in pharmaceutical CRM. How would you describe the integration process…
The acquisition of Jerini has to be one of the biggest milestones for Shire Deutschland in its recent history. How have the synergies developed between the two companies, and how…
You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back to 1987, when I…
Roche, once a true pharmaceutical company, is now recognized by its capacity to create a unique business model that allowed to become the world’s largest biotech company with truly differentiated…
Having experienced many years at big pharmaceutical companies, you recently moved into the booming biotech sector by joining Biogen Idec in 2007. What made you make such a decision? The…
Your father was the founder of Dr. Franz Köhler Chemie – that carries his name – and was a very well respected doctor among the German medical and pharmaceutical community.…
See our Cookie Privacy Policy Here